OTC:PTPI | Cash Flow Statement | Petros Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$955,625.00
2026-03-31-$987,036.00-$784,272.00
2025-12-31-$336,506.00-$933,544.00$0.00
2025-09-30-$922,723.00
2025-06-30$5.43M
2025-03-31-$2.26M-$1.66M$8.71M
2024-12-31-$9.27M$656,093.00$965,405.00$5,449.00-$5,449.00-$1.14M
2024-09-30-$2.22M$739,449.00
2024-06-30-$662,026.00$717,838.00
2024-03-31-$2.16M$717,839.00-$1.13M-$1.12M
2023-12-31$318,150.00$802,582.00-$2.26M-$2.37M
2023-09-30-$4.55M$826,795.00
2023-06-30-$2.55M$826,795.00
2023-03-31-$1.39M$826,795.00-$748,363.00-$357,833.00
2022-12-31-$4.22M$916,274.00-$1.57M-$185,058.00
2022-09-30-$13.83M$1.56M
2022-06-30-$1.81M$1.56M
2022-03-31-$174,224.00$1.56M-$5.28M-$900,000.00
2021-12-31-$8.19M$1.69M-$8.3M$24.02M
2021-09-30-$1.7M$1.73M
2021-06-30-$2.11M$1.73M
2021-03-31$3.01M$1.73M-$446,581.00-$2.13M
2020-12-31-$5.44M$1.68M-$4.52M$0.00$0.00$20.99M
2020-09-30-$3.3M$1.66M
2020-06-30-$5.76M$1.66M
2020-03-31-$6.08M$1.66M-$2.38M$4,429.00-$4,429.00$1.38M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$1.91M-$6.73M$8.16M
2024-12-31-$14.32M$2.83M-$2.6M$24,587.00-$24,587.00-$7M
2023-12-31-$8.16M$3.28M-$7.63M$11.54M
2022-12-31-$20.04M$5.6M-$12.8M-$1.62M
2021-12-31-$8.99M$6.88M-$11.86M$18.57M
2020-12-31-$20.59M$6.66M-$15.31M$4,633.00-$4,633.00$30.3M